CD4


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2024
Historique:
received: 14 11 2023
accepted: 09 07 2024
medline: 6 8 2024
pubmed: 6 8 2024
entrez: 6 8 2024
Statut: epublish

Résumé

The proximity of activated T cells and mast cells in the lesional skin of patients with chronic spontaneous urticaria (CSU) is held to contribute to the development of wheals and angioedema. In a previous study, we demonstrated that increased IL-17 expression in T cells and mast cells in skin lesions of patients with CSU is associated with T/mast cell proximity, but the mechanisms that drive T cell/mast cell co-localization remain unknown. To assess if chemokines expressed in lesional CSU skin contribute to T cell/mast cell proximity. Biopsies from lesional CSU skin were compared to biopsies from healthy skin for expression of CCR5 and its ligand CCL3 by CD4 Numbers of CCR5-positive CD4 The close proximity of T cells and mast cells in the skin of severe CSU may be driven, at least in part by increased CCR5 and CCL3 expression. Therapies that target CCL3 interaction with CCR5 should be assessed for their effects in CSU.

Sections du résumé

Background UNASSIGNED
The proximity of activated T cells and mast cells in the lesional skin of patients with chronic spontaneous urticaria (CSU) is held to contribute to the development of wheals and angioedema. In a previous study, we demonstrated that increased IL-17 expression in T cells and mast cells in skin lesions of patients with CSU is associated with T/mast cell proximity, but the mechanisms that drive T cell/mast cell co-localization remain unknown.
Objectives UNASSIGNED
To assess if chemokines expressed in lesional CSU skin contribute to T cell/mast cell proximity.
Patients and methods UNASSIGNED
Biopsies from lesional CSU skin were compared to biopsies from healthy skin for expression of CCR5 and its ligand CCL3 by CD4
Results UNASSIGNED
Numbers of CCR5-positive CD4
Conclusions UNASSIGNED
The close proximity of T cells and mast cells in the skin of severe CSU may be driven, at least in part by increased CCR5 and CCL3 expression. Therapies that target CCL3 interaction with CCR5 should be assessed for their effects in CSU.

Identifiants

pubmed: 39104520
doi: 10.3389/fimmu.2024.1327040
pmc: PMC11298339
doi:

Substances chimiques

Chemokine CCL3 0
Receptors, CCR5 0
CCR5 protein, human 0
CCL3 protein, human 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1327040

Informations de copyright

Copyright © 2024 Mubariki, Samara, Gimenez-Arnua, Maurer, Bejar, Toubi and Vadasz.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Auteurs

Raeda Mubariki (R)

The Unit of Proteomics and Flow Cytometry, Allergy and Clinical Immunology, Bnai-Zion Medical Center, Faculty of Medicine, Technion, Haifa, Israel.

Reem Samara (R)

Department of Pathology, Bnai-Zion Medical Center, Faculty of Medicine, Technion, Haifa, Israel.

Anna Maria Gimenez-Arnua (AM)

Department of Dermatology, Hospital del Mar & Research Institute, Universitat Pompeu Fabra, Barcelona, Spain.

Marcus Maurer (M)

Institute of Allergology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Immunology and Allergology, Berlin, Germany.

Jacob Bejar (J)

Department of Pathology, Bnai-Zion Medical Center, Faculty of Medicine, Technion, Haifa, Israel.

Elias Toubi (E)

The Unit of Proteomics and Flow Cytometry, Allergy and Clinical Immunology, Bnai-Zion Medical Center, Faculty of Medicine, Technion, Haifa, Israel.

Zahava Vadasz (Z)

The Unit of Proteomics and Flow Cytometry, Allergy and Clinical Immunology, Bnai-Zion Medical Center, Faculty of Medicine, Technion, Haifa, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH